was semaglutide banned 1 in 4 Medicare beneficiaries with obesity could get Wegovy despite coverage ban FDA Ban on Compounded GLP-1

The FTCs April 2024 warning letters specifically referenced device patents on auto-injectors for weight-loss and diabetes treatments, signaling regulatory awareness of this risk

Patients with Any Prior Mental Health Diagnosis A large de-identified health records study found that patients with any pre-existing mental health condition had more than double the risk of developing an eating disorder within two years of GLP-1 initiation

doi: 10.1016/j.molcel.2010.05.004 21 ZhangYLiuTMeyerCAEeckhouteJJohnsonDSBernsteinBEet al

The analysis demonstrated a pooled effect size of SMD = 0.60 (95% CI: 0.29, 0.92

While its benefits for weight loss, diabetes management, and cardiovascular outcomes are already well known, Ozempics new indication highlights its potential to protect kidney health and improve long-term health outcomes

Decrease fatigue Increase energy Support joint health and positive mind frame Amino Acids Building blocks to create protein